NIP Group Inc. (NASDAQ: NIPG) received a Nasdaq Deficiency Letter on March 24, 2026, and the company announced the notice on March 27, 2026. The letter cites that the company’s American depositary shares (ADSs) had closed below the $1.00 minimum bid price for 32 consecutive business days.
Under Nasdaq Listing Rule 5450(a)(1), a listed company must maintain a bid price of at least $1.00 per share. Failure to do so triggers a deficiency notice. Nasdaq Listing Rule 5550(a)(2) grants the company 180 calendar days to regain compliance, ending on September 21, 2026. To satisfy the requirement, NIPG must have its ADSs close at or above $1.00 for at least 10 consecutive business days within that period.
The deficiency reflects a prolonged decline in share price driven by investor concerns over the company’s financial performance. NIPG reported a net loss of $136.3 million in Q2 2025, even as revenue rose 55.5% year‑over‑year to $61.2 million. The trailing twelve‑month net loss reached $215.9 million as of December 3, 2025. Management projects positive adjusted EBITDA in the second half of 2025 and an annualized revenue run rate of $300 million, with $200 million from Bitcoin mining and $100 million from entertainment.
The company has stated it will take all reasonable measures to regain compliance. Typical strategies include a sustained market recovery, a reverse stock split, or enhanced investor communication. Nasdaq has recently tightened rules around reverse splits, limiting their use if they would cause non‑compliance with other listing standards.
No significant market reaction or analyst rating changes have been reported following the deficiency notice. The primary concern for investors remains the company’s ability to lift its share price above the $1.00 threshold within the 180‑day window.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.